KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $909.0 million.

  • Quest Diagnostics' Free Cash Flow rose 67.60% to $419.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 36.17%. This contributed to the annual value of $909.0 million for FY2024, which is 5.21% up from last year.
  • According to the latest figures from FY2024, Quest Diagnostics' Free Cash Flow is $909.0 million, which was up 5.21% from $864.0 million recorded in FY2023.
  • Over the past 5 years, Quest Diagnostics' Free Cash Flow peaked at $1.8 billion during FY2021, and registered a low of $864.0 million during FY2023.
  • For the 3-year period, Quest Diagnostics' Free Cash Flow averaged around $1.0 billion, with its median value being $909.0 million (2024).
  • Its Free Cash Flow has fluctuated over the past 5 years, first spiked by 88.26% in 2020, then crashed by 34.25% in 2023.
  • Yearly analysis of 5 years shows Quest Diagnostics' Free Cash Flow stood at $1.6 billion in 2020, then climbed by 15.31% to $1.8 billion in 2021, then declined by 28.20% to $1.3 billion in 2022, then plummeted by 34.25% to $864.0 million in 2023, then grew by 5.21% to $909.0 million in 2024.